Eurofins Pharma Services Newsletter 10 - February 2015
ARTICLES:
- Eurofins Optimed - the leading partner in Early Clinical Development
- Aerosol challenge for Container Closure Integrity studies
- Genotoxicity tests for medical devices: what's new in ISO 10993-3: 2014?
- EN ISO 22442 compliance for Virus Inactivation studies on Medical Devices using animal tissues and their derivatives
- Implementation of 3R-principles by Eurofins partner laboratory BSL BIOSERVICE: Determination of in vivo starting dose with in vitro methods
- Eurofins expands its GMP footprint in Spain
- Pharma Events
> Download the pdf version of the newsletter N°10
Receive the next newsletter via email
